Highly active disease and access to disease-modifying treatments in patients with relapsing-remitting multiple sclerosis in Poland.
Waldemar BrolaMonika Adamczyk-SowaAlina KułakowskaJoanna GłażewskaAnna SmagaHalina Bartosik-PsujekPublished in: Neurologia i neurochirurgia polska (2022)
An urgent change is required in the reimbursement criteria in order to expand access to second-line DMTs for patients with relapsing-remitting MS in Poland.